Net Clinical Benefit of Direct Oral Anticoagulants in Patients With Cancer and Venous Thromboembolism: A Systematic Review and Trade-Off Analysis

Background: Venous thromboembolism (VTE) is highly prevalent in cancer patients. Recent guidelines recommend considering direct oral anticoagulants (DOACs) for the treatment of cancer-associated thrombosis (CAT). However, direct head-to-head comparisons among DOACs are lacking, and almost no net cli...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Front Cardiovasc Med
Hauptverfasser: Yan, Yi-Dan, Ding, Zheng, Pan, Mang-Mang, Xia, Qing, Cui, Jiu-Jie, Wang, Li-Wei, Zhang, Chi, Gu, Zhi-Chun
Format: Artigo
Sprache:Inglês
Veröffentlicht: Frontiers Media S.A. 2020
Schlagworte:
Cardiovascular Medicine
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7693545/
https://ncbi.nlm.nih.gov/pubmed/33304929
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcvm.2020.586020
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge